Testicular Choriocarcinoma Metastatic to the Skin: an Additional Case and Literature Review Lily L
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Pure Choriocarcinoma of the Ovary: a Case Report
Case Report J Gynecol Oncol Vol. 22, No. 2:135-139 pISSN 2005-0380 DOI:10.3802/jgo.2011.22.2.135 eISSN 2005-0399 Pure choriocarcinoma of the ovary: a case report Lin Lv1, Kaixuan Yang2, Hai Wu1, Jiangyan Lou1, Zhilan Peng1 Departments of 1Obstetrics and Gynecology and 2Pathology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China Pure ovarian choriocarcinomas are extremely rare and aggressive tumors which are gestational or nongestational in origin. Due to the rarity of the tumor, there is a lack of information on the clinicopathologic features, diagnosis, and treatment. We report a case of a pure ovarian choriocarcinoma, likely of nongestational origin, treated by cytoreductive surgery in combination with postoperative chemotherapy. The patient was free of disease after a 12month followup. Keywords: Choriocarcinoma, Nongestational, Ovary INTRODUCTION CASE REPORT Pure ovarian choriocarcinomas are extremely rare malignan A 48yearold woman was admitted to our department cies which are of gestational or nongestational in origin. with a 6month history of irregular vaginal bleeding and a The gestational type may arise from an ectopic ovarian pre 1month history of a palpable abdominal mass. She had a gnancy or present as a metastasis from a uterine or tubal nor mal vaginal delivery at 26 years of age and had no recent choriocarcinoma, while the nongestational type is a rare history of normal pregnancies, molar gestations, or abortions. germ cell tumor with trophoblastic differentiation. The esti The physical examination revealed abdominal tenderness and mated incidence of gestational ovarian choriocarcinomas a fixed mass arising from the pelvis to 3 cm below the um is 1 in 369 million pregnancies [1]. -
Male Genital Cancers in the US in 2015 Frequency of Types
5/22/2015 Male Genital Cancers in Germ Cell Tumors of the Testis the US in 2015 Pathology, Immunohistochemistry, and the Often Confusing Estimated Number Site Appearance of Their Metastases of Cases Prostate 220,800 Charles Zaloudek, MD Bladder 56,320 Department of Pathology Kidney 38,270 UCSF Testis 8430 Germ Cell Tumors of the Testis Frequency of Types Intratubular Germ Cell Neoplasia, Unclassified (IGCNU) Intratubular Germ Cell Neoplasia, Specific Types • Seminoma is the Tumor Type % Seminoma most common pure type Spermatocytic Seminoma Mixed GCT 78 Embryonal Carcinoma • Mixed germ cell Embryonal Yolk Sac Tumor tumor is the most 16 Choriocarcinoma common CA Other Trophoblastic Tumors nonseminomatous Teratoma 5 Teratoma germ cell tumor Yolk Sac 2 Mixed Germ Cell Tumor Tumor Calgary, Canada Mod Pathol 2013; 26: 579-586 1 5/22/2015 Intratubular Germ Cell Neoplasia (Carcinoma in Situ) • Precursor of most invasive germ cell tumors • Most likely in high risk patients; found in <1% of the normal population • Thought to be established in the fetus at the time the gonads develop • Switched on at puberty • Lacks 12p abnormalities found in invasive tumors • 50% develop invasive germ cell tumor by 5 years, 70% by 7 years Advances in Anatomic Pathology 2015; 22 (3): 202-212 I had a couple of previous papers returned from American journals, which for a long time did not appreciate the existence of a CIS pattern. However, even there, CIS is now officially recognized…. 2002 2 5/22/2015 The Background IGCNU IGCNU – OCT4 3 5/22/2015 IGCNU – SALL4 IGCNU – CD117 IGCNU – Pagetoid Spread to the Rete Testis Treatment of IGCNU • Unilateral: Orchiectomy • Bilateral: Low dose radiation – Prevents development of invasive germ cell tumor – Causes sterility 4 5/22/2015 Staging Testicular Tumors Clinical Stage I • Limited to testis and epididymis. -
PROSTATE and TESTIS PATHOLOGY “A Coin Has Two Sides”, the Duality of Male Pathology
7/12/2017 PROSTATE AND TESTIS PATHOLOGY “A Coin Has Two Sides”, The Duality Of Male Pathology • Jaime Furman, M.D. • Pathology Reference Laboratory San Antonio. • Clinical Assistant Professor Departments of Pathology and Urology, UT Health San Antonio. Source: http://themoderngoddess.com/blog/spring‐equinox‐balance‐in‐motion/ I am Colombian and speak English with a Spanish accent! o Shannon Alporta o Lindsey Sinn o Joe Nosito o Megan Bindseil o Kandace Michael o Savannah McDonald Source: http://www.taringa.net/posts/humor/7967911/Sindrome‐de‐la‐ Tiza.html 1 7/12/2017 The Prostate Axial view Base Apex Middle Apex Sagittal view Reference: Vikas Kundra, M.D., Ph.D. , Surena F. Matin, M.D. , Deborah A. Kuban, M.Dhttps://clinicalgate.com/prostate‐cancer‐4/ Ultrasound‐guided biopsy following a specified grid pattern of biopsies remains the standard of care. This approach misses 21% to 28% of prostate cancers. JAMA. 2017;317(24):2532‐2542. http://www.nature.com/nrurol/journal/v10/n12/abs/nrurol.2013.195.html Prostate Pathology Inflammation / granulomas Categories Adenosis, radiation, atrophy seminal vesicle Biopsy Benign TURP HGPIN Unsuspected carcinoma is seen in 12% of Atypical IHC TURP cases. glands Prostatectomy Subtype, Gleason, Malignant fat invasion, vascular invasion Other malignancies: sarcomas, lymphomas Benign Prostate Remember Malignant Glands Lack Basal Glands Cells Basal cells Secretory cells Stroma 2 7/12/2017 Benign Prostatic Lesions Atrophy Corpora amylacea (secretions) Seminal Vesicle Acute inflammation GMS Basal cell hyperplasia Basal cell hyperplasia Granulomas (BPH) (BPH) coccidiomycosis Mimics of Prostate Carcinoma Atrophy. Benign Carcinoma with atrophic features Prostate Carcinoma 1. Prostate cancer is the most common, noncutaneous cancer in men in the United States. -
Cytokeratin 7, Inhibin, and P63 in Testicular Germ Cell Tumor: Superior Markers of Choriocarcinoma Compared to Β-Human Chorionic Gonadotropin☆ Sonya J
Human Pathology (2019) 84,254–261 www.elsevier.com/locate/humpath Original contribution Cytokeratin 7, inhibin, and p63 in testicular germ cell tumor: superior markers of choriocarcinoma compared to β-human chorionic gonadotropin☆ Sonya J. Wegman BS, Anil V. Parwani MD, PhD, MBA, Debra L. Zynger MS, MD⁎ Department of Pathology, The Ohio State University Medical Center, Columbus, OH 43210, USA Received 22 August 2018; revised 2 October 2018; accepted 11 October 2018 Keywords: Summary Choriocarcinoma can be difficult to differentiate from other subtypes of testicular germ cell tumor Testicle; and can occur unexpectedly in a distant, late metastasis. The aim of this investigation was to identify a marker Germ cell tumor; superior to β-human chorionic gonadotropin (β-hCG) for choriocarcinoma. Sixty-two primary and metastatic Choriocarcinoma; testicular germ cell tumors (27 choriocarcinomas, 19 yolk sac tumors, 29 embryonal carcinomas, 28 semino- CK7; mas, 22 teratomas, 3 epithelioid trophoblastic tumors [ETTs]) were analyzed for immunohistochemical expres- Inhibin; sion of cytokeratin 7 (CK7), inhibin, p63, and β-hCG. All choriocarcinomas and ETTs were strongly positive p63; for CK7, whereas seminomas were negative and 52% of embryonal carcinomas had weak reactivity. Eighty- β-hCG four percent of yolk sac tumors and 59% of teratomas were CK7 positive. Eighty-nine percent of choriocarci- nomas and 100% of ETTs were positive for inhibin, with reactivity highlighting syncytiotrophoblasts, whereas seminomas, embryonal carcinomas, yolk sac tumors, and teratomas were negative. Eighty-five percent of cho- riocarcinomas expressed p63, with staining mostly in mononucleated trophoblasts, whereas seminomas, em- bryonal carcinomas, and yolk sac tumors were negative. -
Non-Gestational Choriocarcinoma of the Ovary Complicated by Dysgerminoma: a Case Report
6 Case Report Page 1 of 6 Non-gestational choriocarcinoma of the ovary complicated by dysgerminoma: a case report Chi Zhang1,2,3, Yangmei Shen1,2 1Department of Pathology, West China Second University Hospital of Sichuan University, Chengdu, China; 2Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, China; 3The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, China Correspondence to: Yangmei Shen. Department of Pathology, West China Second University Hospital of Sichuan University, Chengdu 610041, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, China. Email: [email protected]. Abstract: To report a case of non-gestational ovarian choriocarcinoma complicated by dysgerminoma and summarize its clinical manifestations, pathological features, treatment, and prognosis. The clinical manifestations, histomorphological features, and immunohistochemical staining findings of a patient with choriocarcinoma complicated by dysgerminoma were recorded. Computed tomography and vaginal color Doppler ultrasound in the outpatient department of our hospital showed that there were large, cystic or solid masses in the pelvic and abdominal cavities, which were considered to be malignant tumors originating from adnexa. Extensive hemorrhage and necrosis were seen in tumor tissues, which were composed of two tumor components: one tumor component contained cytotrophoblasts and syncytiotrophoblasts, and had no placental villous tissue; the other tumor component consisted of medium-sized, round or polygonal cells. Germ cell tumors were considered based on the histological morphological features of the HE-stained slices. -
Gestational Trophoblastic Disease Causes, Risk Factors, and Prevention Risk Factors
cancer.org | 1.800.227.2345 Gestational Trophoblastic Disease Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for gestational trophoblastic disease. ● What Are the Risk Factors for Gestational Trophoblastic Disease? ● Do We Know What Causes Gestational Trophoblastic Disease? Prevention At this time not much can be done to prevent gestational trophoblastic disease. ● Can Gestational Trophoblastic Disease Be Prevented? What Are the Risk Factors for Gestational Trophoblastic Disease? A risk factor is anything that affects your chance of getting a disease such as cancer. Different cancers have different risk factors. For example, exposing skin to strong sunlight is a risk factor for skin cancer. Smoking is a risk factor for cancers of the lung, mouth, larynx (voice box), bladder, kidney, and several other organs. 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 But risk factors don't tell us everything. Having a risk factor, or even several risk factors, does not mean that you will get the disease. And some people who get the disease might not have any known risk factors. Even if a person has a risk factor, it is often very hard to know how much that risk factor may have contributed to the cancer. Researchers have found several risk factors that might increase a woman's chance of developing gestational trophoblastic disease (GTD). Age GTD occurs in women of childbearing age. The risk of complete molar pregnancy is highest in women over age 35 and younger than 20. -
Testicular Mixed Germ Cell Tumors
Modern Pathology (2009) 22, 1066–1074 & 2009 USCAP, Inc All rights reserved 0893-3952/09 $32.00 www.modernpathology.org Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas Anuradha Gopalan1, Deepti Dhall1, Semra Olgac1, Samson W Fine1, James E Korkola2, Jane Houldsworth2, Raju S Chaganti2, George J Bosl3, Victor E Reuter1 and Satish K Tickoo1 1Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; 2Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA and 3Department of Internal Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA Stem cell markers, OCT3/4, and more recently SOX2 and growth differentiation factor 3 (GDF3), have been reported to be expressed variably in germ cell tumors. We investigated the immunohistochemical expression of these markers in different testicular germ cell tumors, and their utility in the differential diagnosis of morphologically difficult-to-classify components of these tumors. A total of 50 mixed testicular germ cell tumors, 43 also containing difficult-to-classify areas, were studied. In these areas, multiple morphological parameters were noted, and high-grade nuclear details similar to typical embryonal carcinoma were considered ‘embryonal carcinoma-like high-grade’. Immunohistochemical staining for OCT3/4, c-kit, CD30, SOX2, and GDF3 was performed and graded in each component as 0, negative; 1 þ , 1–25%; 2 þ , 26–50%; and 3 þ , 450% positive staining cells. The different components identified in these tumors were seminoma (8), embryonal carcinoma (50), yolk sac tumor (40), teratoma (40), choriocarcinoma (3) and intra-tubular germ cell neoplasia, unclassified (35). -
Case Report Non-Gestational Choriocarcinoma As a Cause Of
Bangladesh Journal of Medical Science Vol. 19 No. 04 October’20 Case report Non-gestational choriocarcinoma as a cause of heavy menstrual bleeding-potential: Primary care detection Allen Chai Shiun Chat1, Nani Draman2*, Siti Suhaila Mohd Yusoff3, Rosediani Muhamad4 Abstract: Choriocarcinoma is a malignant trophoblastic disease. It can be divided into gestational and non-gestational type. Gestational choriocarcinoma consists of less than 1% of total endometrial malignancy, and usually is diagnosed via histopathological examination preceding a suspected molar pregnancy. In contrast to gestational choriocarcinoma, only a few cases of primary non-gestational choriocarcinoma were reported in literature reviews. The reported locations for primary non-gestational choriocarcinoma were ovarian and uterine cervix. Due to its low incidence, this disease is often overlooked leading, to delayed diagnosis. In primary care practice, heavy menstrual bleeding is a common presentation. Further evaluations, such as full blood count, ultrasound pelvis or hysteroscopy are usually required. We would like to report a case of potentially earlier detection of non-gestational choriocarcinoma in a 52 years old lady who was presented with heavy menstrual bleeding for a duration of one year. Her symptom persisted despite receiving medical treatment in a few local primary care clinics. She was admitted to a tertiary hospital for symptomatic anaemia which required blood transfusion. Further evaluations, (i.e., laboratory tests, ultrasound, Computed Topography (CT) scan, bone scan, hysteroscopy and laparotomy total abdominal hysterectomy and bilateral salphingo-oophorectomy (TAHBSO) and histological examination) concluded a diagnosis of primary non-gestational choriocarcinoma of fundal uterus with lung metastasis. Keywords: Abnormal uterine bleeding; Heavy menstrual; Primary non-gestational choriocarcinoma of uterus; Pervaginal bleeding Bangladesh Journal of Medical Science Vol. -
Laparoscopically Removed Streak Gonad Revealed Gonadoblastoma
ANTICANCER RESEARCH 37 : 3975-3979 (2017) doi:10.21873/anticanres.11782 Laparoscopically Removed Streak Gonad Revealed Gonadoblastoma in Frasier Syndrome KAZUNORI HASHIMOTO 1, YU HORIBE 1, JIRO EZAKI 2, TOSHIYUKI KANNO 1, NOBUKO TAKAHASHI 1, YOSHIKA AKIZAWA 1, HIDEO MATSUI 1, TOMOKO YAMAMOTO 2 and NORIYUKI SHIBATA 2 Departments of 1Obstetrics and Gynecology, and 2Pathology, Faculty of Medicine, Tokyo Women’s Medical University, Tokyo, Japan Abstract. Background: Frasier syndrome (FS) is case of primary amenorrhea with nephropathy. Prophylatic characterized by gonadal dysgenesis and progressive gonadectomy is recommended due to the high risk of nephropathy caused by mutation in the Wilm’s tumor gene gonadoblastoma in the dysgenetic gonad. (WT1). We report a case of FS in which diagnosis was based on amenorrhea with nephropathy, and laparoscopically- Frasier syndrome (FS) is characterized by male removed streak gonad which revealed gonadoblastoma. Case pseudohermaphroditism and nephropathy, and was first Report: At the age of 3 years, the patient developed described in 46, XY monozygotic twins in 1964 (1). FS is nephrotic syndrome. This later became steroid-resistant and, caused by heterozygous de novo intronic splice site mutations by the age of 16 years, had progressed to end-stage renal in the Wilms’ tumor suppressor gene ( WT1 ), which is a failure with peritoneal dialysis. At the age of 17 years, the regulator of early gonadal and renal development (2). patient presented primary amenorrhea and was referred to We report here a case of FS diagnosed based on our department. Physical examination was consistent with amenorrhea with nephropathy, and laparoscopically removed Tanner 1 development and external genitalia were female streak gonad which revealed gonadoblastoma. -
About Testicular Cancer Overview and Types
cancer.org | 1.800.227.2345 About Testicular Cancer Overview and Types If you have been diagnosed with testicular cancer or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start. ● What Is Testicular Cancer? Research and Statistics See the latest estimates for new cases of testicular cancer and deaths in the US and what research is currently being done. ● Key Statistics for Testicular Cancer ● What’s New in Testicular Cancer Research? What Is Testicular Cancer? Cancer starts when cells begin to grow out of control. Cells in nearly any part of the body can become cancer and spread to other parts of the body. To learn more about how cancers start and spread, see What Is Cancer?1 Cancer that starts in the testicles is called testicular cancer. To understand this cancer, it helps to know about the normal structure and function of the testicles. 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 What are testicles? Testicles (also called testes; a single testicle is called a testis) are part of the male reproductive system. The 2 organs are each normally a little smaller than a golf ball in adult males. They're held within a sac of skin called the scrotum. The scrotum hangs under the base of the penis. Testicles have 2 main functions: ● They make male hormones (androgens) such as testosterone. ● They make sperm, the male cells needed to fertilize a female egg cell to start a pregnancy. Sperm cells are made in long, thread-like tubes inside the testicles called seminiferous tubules. -
Pathogenesis of Intracranial Germ Cell Tumors Reconsidered
Neurosurg Focus 5 (1):Article 1, 1998 Pathogenesis of intracranial germ cell tumors reconsidered Keiji Sano, M.D., D.M.Sc. Department of Neurosurgery, Fuji Brain Institute, University of Tokyo, and Department of Neurosurgery, Teikyo University, Tokyo, Japan The author studied 153 cases of intracranial germ cell tumors (GCTs) through 1994, 62.7% of which showed monotypic histological patterns and 37.3% of which were shown to be mixed tumors. All of these cases, except for six patients who died soon after admission and underwent autopsy, underwent surgery followed by radio- and/or chemotherapy. All patients with choriocarcinoma died within 2 years. Patients with yolk sac tumor (endodermal sinus tumor) and embryonal carcinoma also had poor outcomes. Patients with mature teratoma had 5- and 10-year survival rates of 92.9% each. Patients with immature teratoma and malignant teratoma had a 5- and 10-year survival rate of 70.7% each. Patients with germinoma had a 5-year survival rate of 95.4% and a 10-year survival rate of 92.7%. These results may bring into question the validity of the germ cell theory, because germinoma, which should be the most undifferentiated according to the theory, was the most benign and choriocarcinoma and yolk sac tumor (endodermal sinus tumor), which should be the most differentiated, were the most malignant according to results obtained during follow-up study. Therefore, GCTs other than germinoma may not originate from one single type of cell (primordial germ cells). The embryonic cells of various stages of embryogenesis may perhaps be misplaced in the bilaminar embryonic disc at the time of the primitive streak formation, becoming involved in the stream of lateral mesoderm and carried to the future cranial area to become incorrectly enfolded into the brain at the time of the neural tube formation. -
Leydig Cell Tumour
Non-germ cell tumours of the testis Testis: non-germ cell tumours . Sex cord-stromal tumours Dr Jonathan H Shanks . Haemolymphoid neoplasms . Other neoplasms The Christie NHS . Tumour-like conditions Foundation Trust, Manchester, UK . Metastases The Christie NHS Foundation Trust The Christie NHS Foundation Trust Testis: sex cord-stromal tumours . Leydig cell tumour . Sertoli cell tumour, NOS . Sclerosing Sertoli cell tumour . Large cell calcifying Sertoli cell tumour . Granulosa cell tumour, adult-type . Juvenile granulosa cell tumour . Fibroma . Brenner tumour . Sertoli-Leydig cell tumours (exceptionally rare in testis) Leydig cell tumour . Sex cord-stromal tumour, unclassified . Mixed germ cell-sex cord stromal tumour - gonadoblastoma - unclassified (some may be sex cord stromal tumours with entrapped germ cells – see Ulbright et al., 2000) - collision tumour The Christie NHS Foundation Trust The Christie NHS Foundation Trust Differential diagnosis of Leydig cell TTAGS tumour . Testicular tumour of adrenogenital syndrome (TTAGS) . Multifocal/bilateral lesions (especially in a child/young adult) . Seen in patients with congenital adrenal hyperplasia . Leydig cell hyperplasia (<5mm) . 21 hydroxylase deficience most common . Large cell calcifying Sertoli cell tumour . Elevated serum ACTH . Sertoli cell tumour . Seminoma (rare cases with cytoplasmic clearing) . Benign lesion treated with steroids; partial orchidectomy reserved for steroid unresponsive cases . Mixed sex cord stromal tumours . Sex cord stromal tumour unclassified . Fibrous bands; lipofuscin pigment ++; nuclear pleomorphism but no mitosis . Metastasis e.g. melanoma The Christie NHS Foundation Trust The Christie NHS Foundation Trust Immunohistochemistry of testicular Histopathological and immunophenotypic features of testicular tumour of adrenogenital Leydig cell tumour syndrome Wang Z et al. Histopathology 2011;58:1013-18 McCluggage et al Amin, Young, Scully .